Update: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 07:03:47 -0500 (CDT)
Subject: CDER New 8/25/2008
|
August 25, 2008
- FDA updates the Information for Healthcare Professionals sheet for Tysabri (natalizumab).
- New and Generic Drug Approvals
- Amicar (aminocaproic acid) Oral solution, Xanodyne Pharmaceuticals, Inc., Labeling Revision
- Amicar (aminocaproic acid) Tablets, Xanodyne Pharmaceuticals, Inc., Labeling Revision
- Ceftriaxone (ceftriaxone sodium) Injection, Bedford Laboratories, Approval
- Losartan Potassium Tablets, Aurobindo Pharma, Ltd., Tentative Approval
- Metaglip (glipizide and metformin hydrochloride) Tablets, Bristol-Myers Squibb Co., Labeling Revision
- Mucinex (guaifenesin) Extended-Release Tablets, Adams Respiratory Therapeutics, Package Change
- Pamidronate Disodium Injection, Pliva-Lachema, AS, Approval
- Qvar 40 (beclomethasone dipropionate) Inhalation Aerosol, Teva Global Regulatory Research, LLC, Labeling Revision
- Qvar 80 (beclomethasone dipropionate) Inhalation Aerosol, Teva Global Regulatory Research, LLC, Labeling Revision
- Rocephin (ceftriaxone sodium) Injection, HLR Technology Corp., Labeling Revision
- Rocephin Kit (ceftriaxone sodium and lidocaine) Injection, HLR Technology Corp., Labeling Revision
- Somavert (pegvisomant) Injection, Pharmacia & Upjohn, Labeling Revision
- Sustiva (efavirenz) Capsules, Bristol-Myers Squibb Co., Labeling Revision
- Sustiva (efavirenz) Tablets, Bristol-Myers Squibb Co., Labeling Revision
- Vidaza (azacitidine) Subcutaneous I.V. Injection, Celgene Corp., Efficacy Supplement with Clinical Data to Support
Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 07:48:08 -0500 (CDT)
Subject: CDRH New Update
FDA Home Page | CDRH Home Page | Search | A-Z Index | ||
Date: August 26, 2008 |
The following new items were added to the CDRH web pages on August 25, 2008. Previous CDRH New Items can be found on the CDRHNew Page.
Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 08:28:40 -0500 (CDT)
Subject: U.S. Food & Drug Administration (FDA) CBER's Proposed and Final Rules Update
You are subscribed to CBER's Proposed and Final Rules for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
FEDERAL REGISTER: FDA Regulations; Technical Amendment; Final Rule - 8/25/2008
Update: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 08:48:44 -0500 (CDT)
Subject: What's New at CBER Update
You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
FEDERAL REGISTER: FDA Regulations; Technical Amendment; Final Rule
Posted: 8/26/2008
Update: 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 11:03:12 -0500 (CDT)
Subject: Drug Shortages: Current Drug Shortages; Zanosar (Streptozocin) Injection
|
Drug Shortages: Current Drug Shortages; Zanosar (Streptozocin) Injection
Tue, 26 Aug 2008 11:00:00 -0500
See Web site for additional information on this current drug shortage
Update: 6
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 26 Aug 2008 17:25:07 -0500 (CDT)
Subject: CDER New 8/26/2008
|
August 26, 2008
- Drug Shortages: Current Drug Shortages; Zanosar (Streptozocin) Injection
- New and Generic Drug Approvals
- Aloxi (palonosetron hydrochloride) Capsules, Helsinn Healthcare, SA, Approval
- Monistat 7 (miconazole nitrate) Vaginal Cream, Johnson & Johnson Healthcare Products, Manufacturing Change or Addition
- Precose (acarbose) Tablets, Bayer HealthCare Pharmaceuticals, Labeling Revision
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420